Rankings and awards
Novartis is honored to receive numerous awards for progress in research and development, our working environment, and our corporate responsibility activities.
A selection is featured here.
Top 50 Companies for Diversity 2015
Novartis Pharmaceuticals Corporation has been named the top company for diversity in the US, the first company to ever be at number one two years in a row, in DiversityInc's Top 50 Companies for Diversity.
Novartis named in top ten of Aon Hewitt’s Global Top Companies for Leaders® (TCFL).
The Aon Hewitt Top Companies for Leaders® list recognizes 25 global companies for their outstanding commitment to cultivating engaged, resilient, and talented leaders. Novartis is the highest ranked healthcare company and shares the honor with a prestigious role call of companies, including General Electric, Procter & Gamble, IBM and 3M. Listed 9th, Novartis is the highest ranked healthcare company and highest ranked European company to be named.
Novartis named a Thomson Reuters 2014 Top 100 Global Innovator, recognizing achievement as one of the world’s most innovative companies.
The program, an initiative of the IP & Science business of Thomson Reuters, honors the 100 corporations and institutions around the world that are at the heart of innovation.
Novartis among top 20 best performing companies worldwide in carbon emissions from 2005 to 2012
Of 100 companies analyzed, Novartis ranked #18 across all industries, #4 in the healthcare sector and #1 in Switzerland.
Novartis recognized among world’s most sustainable companies in Corporate Knights Global 100
Inclusion in the 2014 index acknowledges Novartis leadership in key areas of corporate responsibility. Companies named to the Global 100 are recognized as the top overall sustainability performers in their respective industries.
Novartis wins Scrip Award for Jian Kang Kuai Che healthcare project in China
Novartis was honored with the first ever "Scrip Award for Best Advance in an Emerging Market." Novartis won for its Jian Kang Kuai Che healthcare project in China, which works to improve healthcare conditions in rural Xinjiang through educational programs in schools and by recruiting and training healthcare workers.
Novartis listed in STOXX Global ESG Leaders Index
For the third consecutive year, Novartis remains in the STOXX Global ESG Leaders indices – comprising the leading global companies in terms of ESG (environmental, social and governance) performance.
Novartis recognized among 25 best multinational employers by Great Place to Work® Institute
The Top 25 World’s Best Multinational Workplaces is the world’s largest annual study of workplace excellence, identifying the top 25 best multinationals in terms of workplace culture.
Novartis Pharmaceutical US chosen for 2013 list of best employers for mothers.
Working Mother magazine selected the Novartis Pharmaceuticals Division in the US for its 2013 list of the best employers for moms. The magazine highlighted the Global Executive Female Leadership Program supporting career development of women and child care support.
Novartis was accredited as the first global CEO Cancer Gold Standard employer by the CEO Roundtable on Cancer.
The standard recognizes organizations that encourage healthy lifestyles and provide employees with cancer prevention, detection, and treatment programs.
Award of Excellence for Innovations in Diversity
Research shows diverse leadership teams deliver better business results. In executive teams, the magic ratio has been shown to be 30% women. The innovative Novartis Pharmaceuticals “Executive Female Leadership Program” was recently recognized by Profiles in Diversity Journal.
Fortune 500 World’s Biggest Corporations
Novartis listed as the third largest healthcare company worldwide.
2013 European Graduate Barometer
Novartis enters the list of the 50 preferred employers among European Engineering/IT students.
SMS for Life has been recognized by Sustainia as one of the world's top 100 innovative, sustainable solutions for 2013
Fortune's World's Most Admired Companies 2013
Novartis ranked top pharmaceutical company in Fortune's World's Most Admired Companies 2013 for the third time in a row.